These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16938322)

  • 1. The pioneers of venom production for Australian antivenoms.
    Mirtschin P
    Toxicon; 2006 Dec; 48(7):899-918. PubMed ID: 16938322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twentieth century toxinology and antivenom development in Australia.
    Winkel KD; Mirtschin P; Pearn J
    Toxicon; 2006 Dec; 48(7):738-54. PubMed ID: 17030053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A definitive study of snakebite. 1968.
    Snyder CC; Pickins JE; Knowles RP; Emerson JL; Hines WA
    Wilderness Environ Med; 2001; 12(4):276-9. PubMed ID: 11769926
    [No Abstract]   [Full Text] [Related]  

  • 5. Envenoming and antivenom use in Australia.
    White J
    Toxicon; 1998 Nov; 36(11):1483-92. PubMed ID: 9792162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current research into snake antivenoms, their mechanisms of action and applications.
    Silva A; Isbister GK
    Biochem Soc Trans; 2020 Apr; 48(2):537-546. PubMed ID: 32196542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Australian Snakebite Project, 2005-2015 (ASP-20).
    Johnston CI; Ryan NM; Page CB; Buckley NA; Brown SG; O'Leary MA; Isbister GK
    Med J Aust; 2017 Aug; 207(3):119-125. PubMed ID: 28764620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13).
    Isbister GK; O'Leary MA; Elliott M; Brown SG
    Med J Aust; 2012 Aug; 197(3):173-7. PubMed ID: 22860796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could this be snakebite?
    Hawdon GM; Winkel KD
    Aust Fam Physician; 1997 Dec; 26(12):1386-91, 1393-4. PubMed ID: 9470292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bites in Australian snake handlers--Australian snakebite project (ASP-15).
    Isbister GK; Brown SG;
    QJM; 2012 Nov; 105(11):1089-95. PubMed ID: 22875778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
    Alomran N; Blundell P; Alsolaiss J; Crittenden E; Ainsworth S; Dawson CA; Edge RJ; Hall SR; Harrison RA; Wilkinson MC; Menzies SK; Casewell NR
    Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivenom efficacy or effectiveness: the Australian experience.
    Isbister GK
    Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hugh Alistair Reid OBE MD: investigation and treatment of snake bite.
    Hawgood BJ
    Toxicon; 1998 Mar; 36(3):431-46. PubMed ID: 9637363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22).
    Ryan NM; Kearney RT; Brown SG; Isbister GK
    Clin Toxicol (Phila); 2016; 54(1):27-33. PubMed ID: 26490786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxin-centric development approach for next-generation antivenoms.
    Laustsen AH
    Toxicon; 2018 Aug; 150():195-197. PubMed ID: 29857088
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.
    Currie BJ
    Toxicon; 2006 Dec; 48(7):941-56. PubMed ID: 16930660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis.
    Isbister GK; Brown SG; MacDonald E; White J; Currie BJ;
    Med J Aust; 2008 Apr; 188(8):473-6. PubMed ID: 18429716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.